Bone tissue engineering and repair by gene therapy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Many clinical conditions require the stimulation of bone growth. The use of recombinant bone morphogenetic proteins does not provide a satisfying solution to these conditions due to delivery problems and high cost. Gene therapy has emerged as a very promising approach for bone repair that overcomes limitations of protein-based therapy. Several preclinical studies have shown that gene transfer technology has the ability to deliver osteogenic molecules to precise anatomical locations at therapeutic levels for sustained periods of time. Both in-vivo and ex-vivo transduction of cells can induce bone formation at ectopic and orthotopic sites. Genetic engineering of adult stem cells from various sources with osteogenic genes has led to enhanced fracture repair, spinal fusion and rapid healing of bone defects in animal models. This review describes current viral and non-viral gene therapy strategies for bone tissue engineering and repair including recent work from the author's laboratory. In addition, the article discusses the potential of gene-enhanced tissue engineering to enter widespread clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GOVENDER, S., CSIMMA, C., GENANT, H. K., & VALENTIN-OPRAN, A. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200212000-00001 · Cited by 1,308
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538 · cited 1×
“These challenges are currently addressed by developing vectors with enhanced tropism and less immunogenity (64, 65).”
Cited by
Bone tissue engineering: A review in bone biomimetics and drug delivery strategies
Porter, J. R., Ruckh, T. T., & Popat, K. C. (2009) · Biotechnology Progress · doi:10.1002/btpr.246 · Cited by 809
Toward delivery of multiple growth factors in tissue engineering
Chen, F.-M., Zhang, M., & Wu, Z.-F. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.053 · Cited by 649
Spinal Fusion in the Next Generation: Gene and Cell Therapy Approaches
Barba, M., Cicione, C., Bernardini, C., Campana, V., Pagano, E., Michetti, F., Logroscino, G., & Lattanzi, W. (2014) · The Scientific World Journal · doi:10.1155/2014/406159 · Cited by 514
Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine
Sundelacruz, S., & Kaplan, D. L. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.03.017 · Cited by 306
Park, S. Y., Ki, C. S., Park, Y. H., Jung, H. M., Woo, K. M., & Kim, H. J. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0328 · Cited by 120
Metadata
- Authors
- Betz, V.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2008
- Volume
- 13
- Issue
- 13
- Pages
- 833
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/2724
- OpenAlex
- W1542853031
- Cited by
- 69
- References
- 2
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone tissue engineering and repair by gene therapy. https://app.cochat.ai/papers/10.2741/2724
- The paper
- Betz, V. (2008). Bone tissue engineering and repair by gene therapy. Frontiers in Bioscience. https://doi.org/10.2741/2724
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.